Xeltis Revenue and Competitors
Estimated Revenue & Valuation
- Xeltis's estimated annual revenue is currently $22.3M per year.
- Xeltis's estimated revenue per employee is $251,000
Employee Data
- Xeltis has 89 Employees.
- Xeltis grew their employee count by 24% last year.
Xeltis's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | VP US Clinical Affairs | Reveal Email/Phone |
4 | VP Clinical Business Development | Reveal Email/Phone |
5 | Director R&D | Reveal Email/Phone |
6 | Director Regulatory Affairs | Reveal Email/Phone |
7 | Director Clinical Operations | Reveal Email/Phone |
8 | Director Quality | Reveal Email/Phone |
9 | Chief Technology Officer | Reveal Email/Phone |
10 | Finance Director (ai) | Reveal Email/Phone |
Xeltis Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.3M | 5 | -81% | N/A | N/A |
#2 | $1M | 4 | -33% | N/A | N/A |
#3 | $0.5M | 2 | 0% | N/A | N/A |
#4 | $3.8M | 15 | 0% | N/A | N/A |
#5 | $108.2M | 431 | 38% | N/A | N/A |
#6 | $23.8M | 95 | -19% | N/A | N/A |
#7 | $2.3M | 9 | N/A | N/A | N/A |
#8 | $12M | 48 | -11% | N/A | N/A |
#9 | $0.3M | 1 | -80% | N/A | N/A |
#10 | $4.5M | 18 | -31% | N/A | N/A |
What Is Xeltis?
Xeltis is a clinical-stage company developing medical devices enabling cardiovascular restoration. Xeltis medical device platform comprises the first-ever bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR): the natural restoration of the complex body part they replace upon implantation. www.xeltis.com Please note: Xeltis cannot provide any information to individual patients in relations to clinical trials, due to privacy and clinical practice regulations; please contact the relevant trial centres for any enquiries. www.xeltis.com
keywords:N/A
N/A
Total Funding
89
Number of Employees
$22.3M
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Xeltis News
... Scope And Outlook | Abbott Laboratories, BioVentrix Inc., Edwards Lifesciences Corp., CryoLife Inc., Xeltis AG, NeoChord Inc.
These findings from an ongoing first-in-human study of the Axess graft (Xeltis) are being presented for the first time by trial investigator...
Other Companies in Zurich
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $19M | 89 | 20% | N/A |
#2 | $38.4M | 89 | 48% | N/A |
#3 | $12.6M | 90 | 55% | N/A |
#4 | $12.6M | 90 | N/A | N/A |
#5 | $16.2M | 90 | 27% | N/A |